Lifeboat Foundation

Hmmm; I do know for many there is a set of genetic mutations that seem to sit dormat and eventually triggered by environment conditions.

(Reuters Health) — The risk of some childhood cancers might vary depending on where a child’s mother was born, a new study suggests.

For example, some brain and kidney cancers occurred less often in children whose Hispanic mothers were born outside the U.S. than in youngsters whose Hispanic or white mothers were born in the U.S., researchers found.

Continue reading “Kids’ cancer risk might be tied to where mom was born” »

University of Leicester. (2016, April 25). Researchers shed light on the role of inositol phosphate molecules in gene regulatory complexes. ScienceDaily. Retrieved April 26, 2016 from www.sciencedaily.com/releases/2016/04/160425112511.htm

Very eye opening: North America has the largest market for silent cancer therapeutic, followed by Europe.

Silent cancer refers to those types of cancer which are undiagnosed in early stages. This is due to asymptomatic nature of the disease which makes it difficult to identify the disease till it progresses to advanced stages. Major silent types of cancer include brain, cervix, esophagus, mouth and larynx, ovarian, pancreatic, kidney, and liver cancer. Some silent types of cancer such as ovarian cancer, esophageal cancer, and pancreatic cancer show symptoms in their early stages. Ovarian cancer occurs in epithelium or lining cells of the ovary. Major signs and symptoms of ovarian cancer include pain or cramps in the belly, nausea, abnormal vaginal bleeding, and bloating. Pancreatic cancer is one of the fastest growing types of cancer worldwide. Esophagus cancer is more common among the older population, compared to adults. This cancer is mainly treated by chemotherapy, surgery, and radiosurgery. Moreover, physicians also use combination therapy for the treatment of silent cancer. For instance, the combination of radiation therapy and chemotherapy is very effective in the treatment of silent cancer.

Continue reading “Silent Cancer Therapeutic Market — Historical, Current and Projected industry size and Recent Industry Trends by 2015 — 2021” »

New project underway to find answers.

The Allen Institute for Brain Science has announced major updates to its online resources available at “brain-map.org” brain-map.org, including a new resource on Aging, Dementia and Traumatic Brain Injury (TBI) in collaboration with UW Medicine researchers at the University of Washington, and Group Health. The resource is the first of its kind to collect and share a wide variety of data modalities on a large sample of aged brains, complete with mental health histories and clinical diagnoses.

“The power of this resource is its ability to look across such a large number of brains, as well as a large number of data types,” says Ed Lein, Ph.D., Investigator at the Allen Institute for Brain Science. “The resource combines traditional neuropathology with modern ‘omics’ approaches to enable researchers to understand the process of aging, look for molecular signatures of disease and identify hallmarks of brain injury.”

Continue reading “Allen Institute releases powerful new data on the aging brain and traumatic brain injury” »

Nice

Quantum computers have been hailed for their revolutionary potential in everything from space exploration to cancer treatment, so it might not come as a surprise that Europe is betting big on the ultra-powerful machines.

A new €1 billion ($1.13 billion) project has been announced by the European Commission aimed at developing quantum technologies over the next 10 years and placing Europe at the forefront of “the second quantum revolution.”

Continue reading “Europe’s billion Euro bet on quantum computing” »

Hyderabad: Infections, haemorrhage, swelling and head injuries are some of the prime reasons for brain surgery but experts say taking the patient under the knife is the last option because of the complexities of the procedure which could lead to disability or death.

Senior doctors said despite advancements in technology, dealing with brain surgeries requires much expertise and continues to be a challenging area.

Senior neurosurgeon Dr Radha Krishna said, “Brain surgeries are complex and the protocol is to first opt for medicines. Nowadays due to diagnostic technologies, even the smallest of lesions or tumours are picked up but it is still important to treat them with medicines.”

Continue reading “Pollution affecting the brain” »

A team of researchers has found a key player in brain tumour formation that may lead to new therapies for a deadly and incurable cancer.

The study published in Nature Neuroscience is the first to show that a protein called OSMR (Oncostatin M Receptor) is required for glioblastoma tumours to form.

Glioblastoma is one of the most deadly cancers, resistant to radiation, chemotherapy and difficult to remove with surgery.

Continue reading “Researchers find potential new treatment target for deadly brain cancer” »

The use of tDCS in the frontopolar cortex of the brain gives an added boost to creativity in the performance of novel tasks, suggesting potential benefits in areas of reasoning and decision making.

This makes me a little nervous because pathways are very fragile and just the smallest change can result is some very bad/ even devastating results in other areas of the brain/ body.

Alzheimer’s remains one of the costliest yet most mysterious conditions in the United States, where an estimated 5.1 million Americans are living with the incurable, progressive disease. But researchers at The Rockefeller University have found that manipulating a protein pathway linked with Alzheimer’s helped improve memory impairment in mice— a finding that offers hope for new treatment in humans. Memory loss is the hallmark symptom of the disease.

Scientists with the Fisher Center for Alzheimer’s Research Foundation at The Rockefeller University used a complex set of imaging technologies and experiments to identify an early trafficking protein pathway (COPI) that affects amyloid precursor protein (APP), which precedes the formation of amyloid plaques. Previous research on Alzheimer’s have targeted this plaque, but scientists haven’t successfully identified a way to halt its progression. There is currently no cure or effective treatment for the disease.

Continue reading “Interfering with brain pathway early could improve memory in Alzheimer’s patients” »